Medical Specialties Industry Financials, Performance and Ratios
-
Industry Score
50.1 /100
Rank 36 out of 131 Industries -
Advance/Decline
126/78
-
No. of Companies204
-
Avg. Market Cap9,556
-
Price to Earning Ratio34.54
-
Price to Earning Growth Ratio3.41
-
Price to Book Ratio12.21
-
Return on Equity18.17
-
Return on Capital Employed-
-
Return on Assets10.42
-
Dividend yield 1 year %0.24 %
-
Net Profit Growth Annual YoY %5.36 %
-
Net Profit Growth Qtr YoY %-36.75 %
-
Net Profit Growth Qtr QoQ %-8.06 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Medical Specialties Industry Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Medical Specialties Peer comparison
Compare all stocks in Medical Specialties industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilent Tech |
|
39,301.4
|
138.6
|
L
 -0.8%
H
138.4
141.2
|
L
 -5%
H
134.6
146.9
|
L
 1.0%
H
134.6
150.1
|
L
 -4.8%
H
134.6
160.3
|
L
 -9.1%
H
96.4
160.3
|
L
 -11.1%
H
96.4
160.3
|
L
 9.2%
H
96.4
179.6
|
L
 272.4%
H
34.2
179.6
|
| Abbott |
|
188,858.9
|
108.6
|
L
 -10.0%
H
105.8
114
|
L
 -12.7%
H
105.8
124.4
|
L
 -13.4%
H
105.8
129.5
|
L
 -14.8%
H
105.8
132.0
|
L
 -7%
H
105.8
141.2
|
L
 -3.7%
H
89.7
141.2
|
L
 -3.8%
H
89.7
142.6
|
L
 175.1%
H
36
142.6
|
| Alcon Inc - Registered Shares |
|
39,797.0
|
81.0
|
L
 -0.7%
H
80.9
82.1
|
L
 1.1%
H
78.3
82.1
|
L
 1.3%
H
76.7
82.5
|
L
 6.9%
H
72.1
82.5
|
L
 -8.5%
H
71.6
99.2
|
L
 7.6%
H
63.8
101.1
|
L
 10.5%
H
55.2
101.1
|
L
H
39.4
101.1
|
| Artivion Inc |
|
2,080.7
|
43.9
|
L
 -0.9%
H
43.6
45.4
|
L
 3.3%
H
42.4
45.4
|
L
 -5.7%
H
41.8
48
|
L
 3.8%
H
41.8
48.3
|
L
 39.0%
H
22.0
48.3
|
L
 245.8%
H
11.4
48.3
|
L
 73.6%
H
9.6
48.3
|
L
 364.3%
H
8.9
48.3
|
| Avanos Medical Inc |
|
608.1
|
13.1
|
L
 1.9%
H
12.9
13.3
|
L
 10.4%
H
11.8
13.3
|
L
 12.3%
H
11.1
13.3
|
L
 13.0%
H
10.6
13.3
|
L
 -19.1%
H
9.3
17.7
|
L
 -55.5%
H
9.3
32.0
|
L
 -72.4%
H
9.3
53.6
|
L
 -46.0%
H
9.3
73.0
|
| Baxter International |
|
10,317.1
|
20.1
|
L
 1.8%
H
19.8
20.4
|
L
 1.2%
H
19.4
20.5
|
L
 5.9%
H
18.7
21.3
|
L
 -11.8%
H
17.4
23.5
|
L
 -36.3%
H
17.4
37.7
|
L
 -54.3%
H
17.4
50.2
|
L
 -74.9%
H
17.4
89.7
|
L
 -43.1%
H
17.4
95.2
|
| Becton, Dickinson and Co. |
|
58,702.5
|
206.0
|
L
 -0.1%
H
204.3
207.6
|
L
 -0.7%
H
203.1
209.3
|
L
 5.3%
H
192.5
209.3
|
L
 9%
H
162.3
209.3
|
L
 -14.3%
H
162.3
251.9
|
L
 -18.8%
H
162.3
287.3
|
L
 -19.4%
H
162.3
287.3
|
L
 49.1%
H
126.3
287.3
|
| Butterfly Network Inc (Class A) |
|
1,187.2
|
4.7
|
L
 6.3%
H
4.3
4.9
|
L
 -5.1%
H
4.0
5.0
|
L
 32.0%
H
3.6
5.0
|
L
 108.9%
H
1.9
5.0
|
L
 20.2%
H
1.3
5.0
|
L
 76.0%
H
0.7
5.0
|
L
 -78.8%
H
0.7
29.1
|
L
H
0.7
29.1
|
| Bio-Rad Laboratories Inc (Class A) |
|
8,233.3
|
305.2
|
L
 -2.0%
H
304.2
315.7
|
L
 -4.1%
H
304.2
323.3
|
L
 1.2%
H
298.8
328.6
|
L
 -7.9%
H
295.0
343.1
|
L
 -13.8%
H
211.4
373.7
|
L
 -33.3%
H
211.4
509.6
|
L
 -48.2%
H
211.4
832.7
|
L
 144.5%
H
122.7
832.7
|
| Bausch + Lomb Corp |
|
6,088.5
|
17.2
|
L
 -0.4%
H
17.1
17.5
|
L
 -0.8%
H
16.9
17.5
|
L
 1.2%
H
16.2
17.9
|
L
 10.0%
H
14.4
17.9
|
L
 0.1%
H
10.5
18.1
|
L
 0.4%
H
10.5
22.0
|
L
H
10.5
22.0
|
L
H
10.5
22.0
|
| Conmed Corp |
|
1,305.6
|
42.2
|
L
 1.4%
H
41.7
42.7
|
L
 1.4%
H
40.7
43.0
|
L
 5.5%
H
39
45.7
|
L
 -12.8%
H
38.3
49.6
|
L
 -40.6%
H
38.3
74.7
|
L
 -56.4%
H
38.3
138.5
|
L
 -64.9%
H
38.3
159.1
|
L
 9.0%
H
35.5
159.1
|
| Cooper Companies |
|
16,227.0
|
82.8
|
L
 0.3%
H
82.2
83.8
|
L
 1.4%
H
80.2
83.8
|
L
 0.1%
H
80.1
85.0
|
L
 10.4%
H
67.2
89.8
|
L
 -13.2%
H
61.8
100.2
|
L
 -3.6%
H
61.8
112.4
|
L
 -12.1%
H
61.1
115.9
|
L
 167.4%
H
31.0
115.9
|
| Danaher |
|
169,580.4
|
240.1
|
L
 -0.8%
H
239.5
242.8
|
L
 0.9%
H
231.1
242.8
|
L
 6.8%
H
224.1
242.8
|
L
 8.8%
H
207.7
242.8
|
L
 -1.7%
H
171.0
258.2
|
L
 -12.5%
H
171.0
281.7
|
L
 3.0%
H
171.0
334.0
|
L
 275.2%
H
61.6
334.0
|
| Edwards Lifesciences |
|
49,000.5
|
84.4
|
L
 -0.8%
H
84.3
86.2
|
L
 1.6%
H
82.4
86.2
|
L
 -1.4%
H
81.3
87.4
|
L
 11.1%
H
75.5
87.9
|
L
 20.7%
H
65.9
87.9
|
L
 6.5%
H
58.9
96.1
|
L
 -3.2%
H
58.9
131.7
|
L
 225.6%
H
25.1
131.7
|
| Glaukos Corp |
|
7,231.0
|
125.9
|
L
 1.4%
H
125.1
130.2
|
L
 20.6%
H
103.1
130.2
|
L
 8.3%
H
94.0
130.2
|
L
 65.9%
H
73.2
130.2
|
L
 -21.0%
H
73.2
163.7
|
L
 159.4%
H
44.3
163.7
|
L
 41.9%
H
33.3
163.7
|
L
 677.6%
H
14.3
163.7
|
| Globus Medical Inc (Class A) |
|
12,666.5
|
94.6
|
L
 0.5%
H
93.7
95.2
|
L
 2.4%
H
91.1
95.2
|
L
 8.7%
H
85.7
101.4
|
L
 50.9%
H
59.5
101.4
|
L
 2.4%
H
51.8
101.4
|
L
 27.8%
H
43.4
101.4
|
L
 43.8%
H
43.4
101.4
|
L
 281.0%
H
19.3
101.4
|
| Haemonetics Corp |
|
3,277.6
|
70.0
|
L
 -0.1%
H
69.8
71.8
|
L
 -7.5%
H
69.8
76.1
|
L
 -12.7%
H
69.8
86.1
|
L
 36.8%
H
49.0
87.3
|
L
 -6.9%
H
47.3
87.3
|
L
 -21.6%
H
47.3
98.0
|
L
 -40.7%
H
43.5
142.1
|
L
 134.7%
H
26.0
142.1
|
| Inspire Medical Systems Inc |
|
2,348.1
|
80.8
|
L
 -16%
H
80.8
97.5
|
L
 -13.2%
H
80.8
97.7
|
L
 -16.3%
H
80.8
102.6
|
L
 -2.4%
H
71.5
147.0
|
L
 -56.3%
H
70.8
203.1
|
L
 -68.1%
H
70.8
330
|
L
 -63.2%
H
70.8
330
|
L
H
22.5
330
|
| Integer Holdings Corp |
|
2,997.2
|
85.5
|
L
 -1.7%
H
85.3
87.6
|
L
 1.0%
H
83.5
87.7
|
L
 8.9%
H
76.2
87.7
|
L
 -20.8%
H
62
112.0
|
L
 -40.3%
H
62
146.4
|
L
 15.3%
H
62
146.4
|
L
 8.4%
H
50.1
146.4
|
L
 130.3%
H
18.1
146.4
|
| Medtronic |
|
129,919.3
|
101.3
|
L
 1.1%
H
100.1
102.1
|
L
 2.6%
H
95.7
102.1
|
L
 2.8%
H
95.2
102.1
|
L
 5.8%
H
89.0
106.3
|
L
 14.7%
H
79.6
106.3
|
L
 25.3%
H
68.9
106.3
|
L
 -14.1%
H
68.9
135.9
|
L
 35.8%
H
68.9
135.9
|
| Mettler-Toledo International |
|
29,378.4
|
1,438.1
|
L
 -0.3%
H
1431
1456.8
|
L
 -3.2%
H
1390.0
1502.5
|
L
 2.5%
H
1384.5
1514.4
|
L
 3.8%
H
1359.6
1525.2
|
L
 8.6%
H
946.7
1525.2
|
L
 -7.9%
H
928.5
1616.0
|
L
 15.5%
H
928.5
1714.8
|
L
 368.3%
H
291.3
1714.8
|
| Envista Holdings Corp |
|
4,013.6
|
24.4
|
L
 -1.1%
H
24.3
25.1
|
L
 0.9%
H
24.0
25.4
|
L
 9.6%
H
21.6
25.4
|
L
 21.6%
H
18.8
25.4
|
L
 18.8%
H
14.2
25.4
|
L
 -33.7%
H
14.2
43.3
|
L
 -32.9%
H
14.2
52.0
|
L
H
10.1
52.0
|
| Owens & Minor Inc |
|
163.2
|
2.1
|
L
 -1.4%
H
2.1
2.3
|
L
 -18.2%
H
2.1
2.7
|
L
 -25.7%
H
1.8
3.0
|
L
 -58.3%
H
1.8
5.6
|
L
 -85.9%
H
1.8
15.5
|
L
 -89.8%
H
1.8
28.4
|
L
 -91.9%
H
1.8
49.2
|
L
 -93.6%
H
1.8
49.2
|
| Penumbra Inc |
|
14,065.0
|
358.5
|
L
 0.2%
H
357.7
360.9
|
L
 14.4%
H
345.2
362.4
|
L
 13.5%
H
290
362.4
|
L
 44.0%
H
221.3
362.4
|
L
 33.7%
H
221.3
362.4
|
L
 44.4%
H
148
362.4
|
L
 45.9%
H
114.9
362.4
|
L
 685.0%
H
40.2
362.4
|
| Koninklijke Philips N.V. (ADR) |
|
28,282.1
|
29.7
|
L
 1.8%
H
29.5
29.8
|
L
 -1.2%
H
28.4
30.3
|
L
 11.6%
H
26.6
30.3
|
L
 4.8%
H
26.1
30.3
|
L
 11.9%
H
21.5
30.3
|
L
 80.0%
H
15.6
32.9
|
L
 -46.3%
H
11.8
61.2
|
L
 23.5%
H
11.8
61.2
|
| Qiagen NV |
|
11,175.4
|
54.3
|
L
 -2.5%
H
53.9
55.1
|
L
 14.4%
H
46.1
57.8
|
L
 13.1%
H
46.1
57.8
|
L
 6.2%
H
45.1
57.8
|
L
 5.5%
H
39.6
57.8
|
L
 -3.6%
H
38.8
57.8
|
L
 -9.5%
H
38.8
65.9
|
L
 114.8%
H
23.1
65.9
|
| Vicarious Surgical Inc (Class A) |
|
17.7
|
2.5
|
L
 3.3%
H
2.5
2.7
|
L
 -11.7%
H
2.4
3
|
L
 14.8%
H
1.8
3.3
|
L
 -56.7%
H
1.8
6.3
|
L
 -82.6%
H
1.8
16.4
|
L
 -99.9%
H
1.8
3199.5
|
L
 -100.0%
H
1.8
14207.0
|
L
H
1.8
14207.0
|
| ResMed |
|
37,272.5
|
255.4
|
L
 -1.5%
H
254.7
264.1
|
L
 -1.6%
H
252.8
264.1
|
L
 4.3%
H
240
264.1
|
L
 -4.8%
H
237.6
270.6
|
L
 3.1%
H
199.9
293.8
|
L
 8.8%
H
132.2
293.8
|
L
 17.6%
H
132.2
301.3
|
L
 372.5%
H
55.1
301.3
|
| Steris PLC |
|
25,606.6
|
260.9
|
L
 -0.1%
H
259.0
263.1
|
L
 -1.3%
H
257.9
269.4
|
L
 2.6%
H
246.7
269.4
|
L
 7.8%
H
232.2
269.4
|
L
 20.2%
H
204.9
269.4
|
L
 27.2%
H
173.2
269.4
|
L
 38.5%
H
159.2
269.4
|
L
 285.9%
H
61.4
269.4
|
| Stevanato Grp Spa |
|
5,230.8
|
19.2
|
L
 -1.4%
H
19.1
19.9
|
L
 -6.4%
H
18.8
21.2
|
L
 -6.7%
H
18.8
22
|
L
 -27.2%
H
18.8
28.0
|
L
 -13.6%
H
17.8
28
|
L
 -2.2%
H
16.6
36.3
|
L
H
13.4
36.3
|
L
H
13.4
36.3
|
| Stryker |
|
137,163.9
|
358.7
|
L
 -1.2%
H
358.4
365.0
|
L
 -0.2%
H
356.6
365.4
|
L
 1.0%
H
344.6
370.9
|
L
 -5.6%
H
344.6
392.6
|
L
 -9.4%
H
329.2
406.2
|
L
 40.0%
H
249.0
406.2
|
L
 47.2%
H
188.8
406.2
|
L
 290.3%
H
92.4
406.2
|
| Smith & Nephew PLC (ADR) |
|
14,040.2
|
33.1
|
L
 0.9%
H
33.0
33.3
|
L
 0.5%
H
32.1
33.3
|
L
 0.8%
H
31.9
34.2
|
L
 -9.4%
H
31.8
37.5
|
L
 28.6%
H
23.9
38.8
|
L
 16.2%
H
21.5
38.8
|
L
 -26.3%
H
21.5
45.7
|
L
 4.7%
H
21.5
52.3
|
| Teleflex Incorporated |
|
4,644.4
|
105.1
|
L
 2.1%
H
103.2
107.1
|
L
 2.0%
H
100.2
107.1
|
L
 -13.8%
H
100.2
127.5
|
L
 -21.0%
H
100.2
137.0
|
L
 -42.4%
H
100.2
185.9
|
L
 -55.4%
H
100.2
276.4
|
L
 -73.0%
H
100.2
449.4
|
L
 -20.8%
H
100.2
449.4
|
| Thermo Fisher |
|
240,246.5
|
639.5
|
L
 0.5%
H
634.8
644.0
|
L
 2.8%
H
606
644.0
|
L
 12.6%
H
565.8
644.0
|
L
 14.6%
H
550.9
644.0
|
L
 11.6%
H
385.5
644.0
|
L
 7.7%
H
385.5
644.0
|
L
 24.8%
H
385.5
672.3
|
L
 385.6%
H
119.8
672.3
|
| Waters |
|
23,844.1
|
400.4
|
L
 0.9%
H
397.0
401.0
|
L
 1.8%
H
376.5
401.0
|
L
 5.9%
H
373.5
408.7
|
L
 14.7%
H
340.1
414.2
|
L
 -3.2%
H
275.1
423.6
|
L
 18.2%
H
231.9
423.6
|
L
 47.6%
H
231.9
428.2
|
L
 221.5%
H
112
428.2
|
| West Pharma Services |
|
17,826.1
|
247.8
|
L
 -2.9%
H
247.0
258.7
|
L
 -9.9%
H
244.7
281.6
|
L
 -9.1%
H
244.7
291.4
|
L
 -11.3%
H
244.7
322.3
|
L
 -28.1%
H
187.4
348.9
|
L
 -4.5%
H
187.4
415.7
|
L
 -17.3%
H
187.4
475.4
|
L
 336.2%
H
53.9
475.4
|
| Zimmer Biomet Holdings |
|
17,348.8
|
87.5
|
L
 1.1%
H
86.4
88.6
|
L
 -1.9%
H
85.8
90.3
|
L
 -1.8%
H
85.8
95.3
|
L
 -14.8%
H
85.3
106.9
|
L
 -20.8%
H
85.3
114.4
|
L
 -29.5%
H
85.3
149.3
|
L
 -42.9%
H
85.3
169.7
|
L
 -5.3%
H
70.0
169.7
|
| BioRad Laboratories Inc |
|
9,003.8
|
312.8
|
L
H
312.8
312.8
|
L
 0.7%
H
312.8
312.8
|
L
 0.7%
H
312.8
312.8
|
L
 -2.6%
H
303.2
315.1
|
L
 -10.4%
H
225.3
359.2
|
L
 -5.9%
H
225.3
373.4
|
L
 -5.9%
H
225.3
373.4
|
L
 -5.9%
H
225.3
373.4
|
| Revvity |
|
13,350.0
|
117.8
|
L
 1.1%
H
116.6
118.3
|
L
 5.6%
H
110.2
118.3
|
L
 22.4%
H
95.9
118.3
|
L
 21.5%
H
88.5
118.3
|
L
 -5%
H
81.4
128.3
|
L
 -14.6%
H
79.5
145.4
|
L
 -21.8%
H
79.5
203.2
|
L
 147.8%
H
39.5
203.2
|
| Aethlon Medical Inc |
|
3.0
|
3.1
|
L
 10.5%
H
2.7
3.2
|
L
 16.4%
H
2.6
3.2
|
L
 6.6%
H
2.2
3.2
|
L
 -39.2%
H
2.2
5.9
|
L
 -94.2%
H
2.2
64
|
L
 -99.2%
H
2.2
695.6
|
L
 -99.9%
H
2.2
9992
|
L
 -100.0%
H
2.2
109078.8
|
| Ainos Inc |
|
13.1
|
1.9
|
L
 1.6%
H
1.9
1.9
|
L
 -2.1%
H
1.8
2.0
|
L
 -10.9%
H
1.6
2.1
|
L
 -48.4%
H
1.6
3.8
|
L
 -39.0%
H
1.6
4.8
|
L
 -89.9%
H
1.6
45.8
|
L
 -97.1%
H
1.6
1781.3
|
L
 394.7%
H
0.1
1781.3
|
| Airsculpt Tech Inc |
|
181.7
|
2.9
|
L
 -1.4%
H
2.8
3.2
|
L
 27.1%
H
2.2
3.2
|
L
 32.9%
H
1.8
3.2
|
L
 -70.3%
H
1.8
12
|
L
 -45.0%
H
1.5
12
|
L
 -42.0%
H
1.5
12
|
L
H
1.5
18.5
|
L
H
1.5
18.5
|
| Align Tech |
|
12,120.0
|
168.9
|
L
 -0.6%
H
167.5
172.4
|
L
 -0.2%
H
164.4
174.7
|
L
 7.1%
H
154.6
174.7
|
L
 24.0%
H
130.2
174.7
|
L
 -25.9%
H
122
237.2
|
L
 -30.5%
H
122
413.2
|
L
 -68.9%
H
122
737.5
|
L
 178.1%
H
57.5
737.5
|
| Angiodynamic Inc |
|
438.1
|
10.6
|
L
 0.6%
H
10.5
10.9
|
L
 3.9%
H
10.2
11.1
|
L
 -20.5%
H
9.7
13.9
|
L
 -9.2%
H
9.7
14.0
|
L
 -11.0%
H
8.3
14.0
|
L
 -20.2%
H
5.3
14.0
|
L
 -42.5%
H
5.3
32
|
L
 -6.1%
H
5.3
32
|
| Anika Therapeutics Inc |
|
135.4
|
9.4
|
L
 -1.4%
H
9.4
9.6
|
L
 -1.6%
H
9.2
9.6
|
L
 -1.9%
H
9.2
9.9
|
L
 -4.0%
H
9.2
10.8
|
L
 -43.1%
H
7.9
18.4
|
L
 -69.7%
H
7.9
32.3
|
L
 -76.1%
H
7.9
48.4
|
L
 -74.3%
H
7.9
75.7
|
| Apyx Medical Corp |
|
162.1
|
4.0
|
L
 -1%
H
4.0
4.2
|
L
 5.1%
H
3.8
4.2
|
L
 13.2%
H
3.4
4.2
|
L
 28.3%
H
2.8
4.4
|
L
 158.2%
H
0.8
4.4
|
L
 49.6%
H
0.8
8.0
|
L
 -62.6%
H
0.8
17.5
|
L
 79.5%
H
0.8
17.5
|
| Accuray Inc |
|
94.1
|
0.8
|
L
 2.5%
H
0.8
0.9
|
L
 -1.2%
H
0.8
0.9
|
L
 -8.8%
H
0.8
0.9
|
L
 -48.5%
H
0.8
1.7
|
L
 -63.0%
H
0.8
3.0
|
L
 -65.1%
H
0.8
4.3
|
L
 -83.7%
H
0.8
6.0
|
L
 -85.6%
H
0.8
6.4
|
| Alphatec Holdings Inc |
|
2,347.1
|
15.8
|
L
 -7.2%
H
15.8
17.1
|
L
 -0.9%
H
15.8
18.0
|
L
 -21.0%
H
15.4
23.3
|
L
 1.9%
H
15.4
23.3
|
L
 36.1%
H
8.8
23.3
|
L
 17.5%
H
4.9
23.3
|
L
 8.5%
H
4.9
23.3
|
L
 338.9%
H
1.2
23.3
|
| Atricure Inc |
|
1,989.7
|
40.0
|
L
 1.9%
H
39.1
40.5
|
L
 7.1%
H
37.3
41.8
|
L
 -2.3%
H
36.1
43.2
|
L
 8.2%
H
30.9
43.2
|
L
 1.0%
H
28.3
43.2
|
L
 -5.7%
H
18.9
59.6
|
L
 -30.0%
H
18.9
89.2
|
L
 114.9%
H
13.4
89.2
|
| Axogen Inc |
|
1,475.9
|
32
|
L
 -3.1%
H
31.5
33.3
|
L
 3.9%
H
30.5
33.6
|
L
 0.1%
H
30.0
34.7
|
L
 83.0%
H
17.1
34.7
|
L
 68.7%
H
9.2
34.7
|
L
 204.8%
H
3.5
34.7
|
L
 68.1%
H
3.5
34.7
|
L
 534.9%
H
3.5
56.9
|
| Bone Biologics Corp |
|
3.2
|
1.8
|
L
 2.3%
H
1.7
1.8
|
L
 9.3%
H
1.6
1.9
|
L
 -3.8%
H
1.4
2.4
|
L
 -28.2%
H
1.3
2.5
|
L
 -71.0%
H
1.3
7.7
|
L
 -99.6%
H
1.3
576.9
|
L
 -100.0%
H
1.3
21600
|
L
H
1.3
169920
|
| BioAffinity Tech Inc |
|
6.1
|
1.4
|
L
 3.8%
H
1.3
1.4
|
L
 7.9%
H
1.3
1.5
|
L
 9.7%
H
1.1
1.5
|
L
 -51.9%
H
1.1
2.8
|
L
 -93.3%
H
1.1
46.5
|
L
 -97.0%
H
1.1
119.7
|
L
H
1.1
466.5
|
L
H
1.1
466.5
|
| Bluejay Diagnostics Inc |
|
1.6
|
0.9
|
L
 24.3%
H
0.7
0.9
|
L
 33.9%
H
0.7
0.9
|
L
 8.8%
H
0.6
0.9
|
L
 -66.0%
H
0.6
2.6
|
L
 -75.6%
H
0.6
10.2
|
L
 -98.9%
H
0.1
140.8
|
L
H
0.1
1000
|
L
H
0.1
1000
|
| Biolife Soln Inc |
|
1,251.4
|
26.0
|
L
 1.7%
H
25.4
26.5
|
L
 7%
H
23.8
26.5
|
L
 3.7%
H
23.3
26.7
|
L
 -6.1%
H
23.3
29.6
|
L
 -5.4%
H
19.1
29.6
|
L
 6.3%
H
8.9
29.6
|
L
 -39.2%
H
8.9
60.7
|
L
 1411.0%
H
1.4
60.7
|
| Biomerica Inc |
|
7.8
|
2.6
|
L
 4.1%
H
2.5
2.6
|
L
 -4.8%
H
2.4
2.8
|
L
 11.3%
H
2.3
2.9
|
L
 -19.7%
H
2.1
3.2
|
L
 328.3%
H
0.4
4.9
|
L
 -11.4%
H
0.2
4.9
|
L
 -58.5%
H
0.2
8.2
|
L
 114.2%
H
0.2
23.4
|
| Bruker Corp |
|
7,917.7
|
52.1
|
L
 0.3%
H
51.6
53.5
|
L
 6.0%
H
46.8
53.5
|
L
 12.1%
H
46.5
56.2
|
L
 34.4%
H
36.1
56.2
|
L
 -13.3%
H
28.5
61
|
L
 -26.2%
H
28.5
94.9
|
L
 -14.4%
H
28.5
94.9
|
L
 137.4%
H
19.6
94.9
|
| BioRestorative Therapies Inc |
|
10.3
|
1.2
|
L
 0.9%
H
1.1
1.2
|
L
 -1.7%
H
1.1
1.2
|
L
 0.9%
H
1
1.3
|
L
 -27.0%
H
1.0
1.7
|
L
 -45.3%
H
1.0
2.6
|
L
 -61.6%
H
1.0
7.1
|
L
 -97.1%
H
1.0
132
|
L
 -100.0%
H
0.4
20040
|
| Biosig Tech Inc |
|
141.2
|
3.5
|
L
 12.3%
H
3.0
3.6
|
L
 7.8%
H
3.0
3.7
|
L
 -8.7%
H
2.9
3.8
|
L
 -33.6%
H
2.9
5.3
|
L
 206.2%
H
0.4
14.1
|
L
 374.0%
H
0.1
14.1
|
L
 -26.4%
H
0.1
14.1
|
L
 23.6%
H
0.1
14.1
|
| Bioventus Inc (Class A) |
|
545.9
|
8.2
|
L
 1.9%
H
8
8.4
|
L
 5.3%
H
7.6
8.4
|
L
 8.8%
H
7.1
8.4
|
L
 14.5%
H
6.5
8.4
|
L
 -20.3%
H
5.8
11.3
|
L
 262.2%
H
0.8
14.4
|
L
H
0.8
19.9
|
L
H
0.8
19.9
|
| Brainsway Ltd (ADR) |
|
473.8
|
24.2
|
L
 4.4%
H
23.7
24.8
|
L
 2.7%
H
21.9
24.8
|
L
 41.4%
H
17.8
24.8
|
L
 48.6%
H
14.3
24.8
|
L
 118.9%
H
7.8
24.8
|
L
 1085.8%
H
1.4
24.8
|
L
 141.2%
H
1.4
24.8
|
L
H
1.4
24.8
|
| Cardio Diagnostics Holdings Inc |
|
3.6
|
2.0
|
L
 7.6%
H
1.8
2.0
|
L
 8.8%
H
1.7
2.0
|
L
 -38.7%
H
1.6
3.7
|
L
 -54.4%
H
1.6
4.5
|
L
 -89.1%
H
1.6
21.2
|
L
 -94.1%
H
1.6
255
|
L
H
1.6
307.5
|
L
H
1.6
307.5
|
| Caredx Inc |
|
1,081.1
|
21.0
|
L
 0.9%
H
20.8
21.5
|
L
 3.4%
H
19.5
21.5
|
L
 8.1%
H
16.9
21.5
|
L
 38.4%
H
14.0
21.5
|
L
 -7.4%
H
11.0
25.6
|
L
 46.7%
H
4.8
34.8
|
L
 -76.0%
H
4.8
96.9
|
L
 301.9%
H
0.8
99.8
|
| Celcuity Inc |
|
5,125.5
|
110.8
|
L
 3.4%
H
106.8
112.7
|
L
 -3.2%
H
103
116.4
|
L
 9.5%
H
98.5
116.4
|
L
 69.1%
H
64.6
116.4
|
L
 888.1%
H
7.6
116.4
|
L
 880.3%
H
7.6
116.4
|
L
 655.6%
H
4.8
116.4
|
L
H
4.0
116.4
|
| Creative Medical Tech Holdings Inc |
|
7.9
|
2.3
|
L
 15.4%
H
1.9
2.3
|
L
 21.6%
H
1.8
2.3
|
L
 6.6%
H
1.5
2.5
|
L
 -39.4%
H
1.5
6.3
|
L
 -3.0%
H
1.5
6.9
|
L
 -52.1%
H
1.5
14.2
|
L
 -97.9%
H
1.5
650
|
L
 -100.0%
H
1.5
525000
|
| Cerus Corp |
|
503.3
|
2.6
|
L
 3.6%
H
2.6
2.7
|
L
 -4.4%
H
2.4
2.8
|
L
 25.4%
H
1.9
3.0
|
L
 59.8%
H
1.4
3.0
|
L
 41.6%
H
1.1
3.0
|
L
 -16.0%
H
1.1
3.5
|
L
 -63.8%
H
1.1
8.4
|
L
 -53.5%
H
1.1
8.9
|
| Check-Cap Ltd |
|
9.4
|
1.5
|
L
 -8.9%
H
1.5
1.7
|
L
 -12.1%
H
1.5
1.8
|
L
 -18.6%
H
1.5
1.9
|
L
 -1.9%
H
1.2
2.1
|
L
 24.4%
H
0.6
3.1
|
L
 -49.3%
H
0.6
5.9
|
L
 -95.3%
H
0.6
89.8
|
L
 -99.7%
H
0.6
173376
|
| CollPlant biotech Ltd - Ordinary Shares New |
|
19.5
|
1.5
|
L
 8.5%
H
1.4
1.7
|
L
 -8.4%
H
1.4
1.7
|
L
 0.7%
H
1.3
1.7
|
L
 -35.4%
H
1.3
2.6
|
L
 -61.8%
H
1.3
5.0
|
L
 -84.8%
H
1.3
14.0
|
L
 -89.4%
H
1.3
24.3
|
L
 -93.6%
H
1.3
24.3
|
| ClearPoint Neuro Inc |
|
422.7
|
14.2
|
L
 1.4%
H
14.0
14.5
|
L
 -7.8%
H
13.5
15.2
|
L
 0.1%
H
13.4
16.6
|
L
 -43.1%
H
12.3
27.3
|
L
 -22.9%
H
9.8
30.1
|
L
 42.4%
H
4.1
30.1
|
L
 -26.7%
H
4.1
31.3
|
L
 -10.0%
H
1.3
31.3
|
| Cardiff Oncology Inc |
|
200.1
|
3.0
|
L
 2.8%
H
2.9
3
|
L
 5.7%
H
2.7
3.0
|
L
 15.6%
H
2.5
3.3
|
L
 33.2%
H
1.9
3.3
|
L
 -15.6%
H
1.9
5.0
|
L
 67.8%
H
0.9
6.4
|
L
 -73.9%
H
0.9
15.0
|
L
 -99.3%
H
0.7
499.0
|
| Castle Biosciences Inc |
|
1,230.3
|
42.2
|
L
 2.9%
H
41.1
43.0
|
L
 3.4%
H
39.7
43.0
|
L
 6.9%
H
37.3
43.0
|
L
 80.1%
H
23.3
43.0
|
L
 57.8%
H
14.6
43.0
|
L
 58.2%
H
9.3
43.0
|
L
 -47.8%
H
9.3
107.7
|
L
H
9.3
107.7
|
| Cytek BioSciences Inc |
|
712.2
|
5.6
|
L
 0.9%
H
5.4
5.7
|
L
 0.2%
H
5.2
5.7
|
L
 12.5%
H
4.9
6.0
|
L
 33.6%
H
3.7
6.2
|
L
 -5.3%
H
2.4
6.2
|
L
 -49.4%
H
2.4
13.8
|
L
H
2.4
28.7
|
L
H
2.4
28.7
|
| Cytosorbents Corp |
|
42.7
|
0.7
|
L
H
0.7
0.7
|
L
 -5.6%
H
0.7
0.7
|
L
 6.3%
H
0.6
0.8
|
L
 -18.1%
H
0.6
0.9
|
L
 -34.6%
H
0.6
1.6
|
L
 -67.6%
H
0.6
4.6
|
L
 -92.7%
H
0.6
11.7
|
L
 -83.2%
H
0.6
15.0
|
| Citius Pharma Inc |
|
17.6
|
0.9
|
L
 6.3%
H
0.8
0.9
|
L
 -1.2%
H
0.7
0.9
|
L
 -20.6%
H
0.6
1.2
|
L
 -49.4%
H
0.6
2.0
|
L
 -73.9%
H
0.6
3.4
|
L
 -97.5%
H
0.1
42.8
|
L
 -97.3%
H
0.1
114
|
L
 -99.9%
H
0.1
937.5
|
| CVRx Inc |
|
171.9
|
6.6
|
L
 8.6%
H
5.9
6.8
|
L
 8.4%
H
5.1
6.8
|
L
 -18.3%
H
5.1
8.7
|
L
 -34.9%
H
5.1
11.3
|
L
 -64.4%
H
4.3
18.2
|
L
 -56.1%
H
4.3
33.1
|
L
H
4.3
33.1
|
L
H
4.3
33.1
|
| Delcath Systems Inc |
|
381.0
|
11.0
|
L
 6.2%
H
10.4
11.2
|
L
 5.8%
H
10.1
11.2
|
L
 9.2%
H
9.7
11.2
|
L
 -3.5%
H
8.1
11.4
|
L
 -26.7%
H
8.1
18.2
|
L
 192.8%
H
2.3
18.2
|
L
 -35.7%
H
2.3
25.2
|
L
 -100.0%
H
2.3
881804000
|
| Alpha Tau Medical Ltd |
|
611.3
|
7.2
|
L
 10.5%
H
6.7
7.3
|
L
 -4.4%
H
6.2
7.9
|
L
 41.4%
H
4.8
7.9
|
L
 70.7%
H
3.4
7.9
|
L
 77.0%
H
2.3
7.9
|
L
 66.7%
H
1.8
7.9
|
L
H
1.8
20.7
|
L
H
1.8
20.7
|
| DexCom |
|
28,830.0
|
73.9
|
L
 2.5%
H
70.8
76.0
|
L
 6.1%
H
68.5
76.0
|
L
 11.9%
H
65.2
76.0
|
L
 6.0%
H
54.1
76.0
|
L
 -14.4%
H
54.1
93.2
|
L
 -31.5%
H
54.1
142
|
L
 -19.5%
H
54.1
164.9
|
L
 307.9%
H
10.7
164.9
|
| Daxor Corp |
|
69.0
|
13.7
|
L
H
13.3
13.7
|
L
 1.6%
H
13.0
13.9
|
L
 6.2%
H
12
14.8
|
L
 1.2%
H
11.4
14.8
|
L
 66.7%
H
6.6
14.8
|
L
 52.1%
H
6.6
14.8
|
L
 4.9%
H
6.6
17.6
|
L
 78.4%
H
3.4
24.1
|
| ElectroCore Inc |
|
56.3
|
7.0
|
L
 -7.1%
H
6.7
7.9
|
L
 7.5%
H
6.4
8
|
L
 53.0%
H
4.4
8
|
L
 41.7%
H
4.4
8
|
L
 -55.8%
H
4.2
19.5
|
L
 23.5%
H
3.1
19.5
|
L
 -81.7%
H
2.9
54.5
|
L
H
2.9
303.8
|
| Ekso Bionics Holdings Inc |
|
26.8
|
7.9
|
L
 0.8%
H
7.8
8.2
|
L
 -2.4%
H
6.9
9.1
|
L
 62.8%
H
4.8
12.7
|
L
 61.1%
H
3.5
12.7
|
L
 -94.5%
H
2.7
155.3
|
L
 -97.9%
H
2.7
704.0
|
L
 -99.6%
H
2.7
3370.5
|
L
 -100.0%
H
2.7
24232.5
|
| Embecta Corp |
|
715.3
|
12.1
|
L
 -2.0%
H
12.1
12.5
|
L
 -5.3%
H
12.0
12.9
|
L
 2.8%
H
11.4
13.0
|
L
 -15.5%
H
11.0
14.9
|
L
 -35.2%
H
9.2
19.7
|
L
 -49.1%
H
9.2
33.9
|
L
H
9.2
63
|
L
H
9.2
63
|
| Establishment Labs Holdings Inc |
|
1,959.7
|
67.4
|
L
 -0.4%
H
67
69.6
|
L
 1.9%
H
63.3
69.6
|
L
 -9.4%
H
63.3
77.5
|
L
 36.7%
H
47
78.2
|
L
 89.7%
H
26.6
78.2
|
L
 -1.9%
H
17
79.9
|
L
 32.5%
H
17
93.8
|
L
H
7.6
93.8
|
| Exact Sciences Corp |
|
19,441.8
|
102.4
|
L
 -0.1%
H
102.3
102.7
|
L
 0.1%
H
102
102.7
|
L
 0.5%
H
101.4
102.7
|
L
 61.4%
H
62.4
102.7
|
L
 88.7%
H
38.8
102.7
|
L
 50.0%
H
38.8
102.7
|
L
 -30.9%
H
29.3
159.5
|
L
 1509.6%
H
4.7
159.5
|
| EDAP TMS S.A. (ADR) |
|
133.5
|
3.6
|
L
 -3.0%
H
3.4
3.8
|
L
 -12.7%
H
3.4
4.1
|
L
 21.4%
H
2.7
4.2
|
L
 50.6%
H
1.8
4.2
|
L
 58.0%
H
1.2
4.2
|
L
 -67.0%
H
1.2
12.7
|
L
 -56.0%
H
1.2
12.7
|
L
 2.3%
H
1.2
12.7
|
| GlucoTrack Inc |
|
3.3
|
3.6
|
L
 -8.2%
H
3.4
3.9
|
L
 -2.7%
H
3.3
4.2
|
L
 -24.3%
H
3.2
4.8
|
L
 -46.0%
H
3.2
7.5
|
L
 -97.6%
H
3.2
140.7
|
L
 -100.0%
H
3.2
22500
|
L
 -100.0%
H
3.2
46800
|
L
 -100.0%
H
3.2
468000
|
| GE HealthCare Tech |
|
37,302.7
|
81.9
|
L
 1.0%
H
81.2
83.2
|
L
 -4%
H
78.3
84.3
|
L
 -1.2%
H
78.3
89.8
|
L
 7.6%
H
70.0
89.8
|
L
 -6.2%
H
57.7
94.8
|
L
 22.6%
H
57.7
94.8
|
L
H
53
94.8
|
L
H
53
94.8
|
| Harvard Bioscience Inc |
|
27.6
|
0.6
|
L
 5.1%
H
0.6
0.6
|
L
 10.7%
H
0.6
0.6
|
L
 -17.3%
H
0.6
0.8
|
L
 51.2%
H
0.4
0.9
|
L
 -68.2%
H
0.3
2.0
|
L
 -78.5%
H
0.3
6.3
|
L
 -85.2%
H
0.3
8.8
|
L
 -78.2%
H
0.3
8.8
|
| Hologic |
|
16,754.5
|
75.1
|
L
 0.0%
H
75.0
75.3
|
L
 -0.1%
H
74.9
75.3
|
L
 0.2%
H
74.2
75.3
|
L
 1.5%
H
73.9
75.3
|
L
 6.7%
H
51.9
75.3
|
L
 -5.7%
H
51.9
87.9
|
L
 -1.1%
H
51.9
87.9
|
L
 121.5%
H
26.5
87.9
|
| Heart Test Laboratories Inc |
|
11.0
|
3.5
|
L
 -5.7%
H
3.4
3.7
|
L
 9.2%
H
3.1
3.7
|
L
 46.2%
H
2.3
3.7
|
L
 2.1%
H
2.0
3.7
|
L
H
2.0
6.5
|
L
 -95.7%
H
2.0
395
|
L
H
2.0
600
|
L
H
2.0
600
|
| Helius Medical Tech Inc (Class A) |
|
132.6
|
3.2
|
L
 6.3%
H
3.0
3.3
|
L
 -8.0%
H
2.8
3.5
|
L
 7.7%
H
2.6
3.7
|
L
 -52.0%
H
2.6
7.2
|
L
 -99.6%
H
2.6
660
|
L
 -100.0%
H
2.6
15732.2
|
L
 -100.0%
H
2.6
786750
|
L
 -100.0%
H
2.6
27168750
|
| Hyperfine Inc (Class A) |
|
121.5
|
1.3
|
L
 -2.3%
H
1.3
1.3
|
L
 0.8%
H
1.1
1.3
|
L
 13.6%
H
0.9
1.3
|
L
 -2.3%
H
0.9
1.3
|
L
 30.2%
H
0.5
2.2
|
L
 31.6%
H
0.5
3.3
|
L
H
0.5
16.6
|
L
H
0.5
16.6
|
| Integra Lifesciences Holdings Corp |
|
949.5
|
12.2
|
L
H
12.2
12.5
|
L
 -2.7%
H
11.8
13.0
|
L
 -3.6%
H
11.8
14.1
|
L
 -23.2%
H
10.9
16.5
|
L
 -51.5%
H
10.9
27.1
|
L
 -78.3%
H
10.9
60.7
|
L
 -82.4%
H
10.9
77.4
|
L
 -60.9%
H
10.9
77.4
|
| Icecure Medical Ltd |
|
45.5
|
0.7
|
L
 3.1%
H
0.6
0.7
|
L
 -2.9%
H
0.6
0.7
|
L
 -2.9%
H
0.6
0.7
|
L
 -20.5%
H
0.6
0.8
|
L
 -46.3%
H
0.6
1.7
|
L
 -48.0%
H
0.5
1.7
|
L
 -64.1%
H
0.5
16
|
L
 -42.6%
H
0.2
16
|
| SeaStar Medical Holding Corp |
|
9.8
|
2.6
|
L
 14.1%
H
2.3
2.6
|
L
 -7.2%
H
2.3
2.8
|
L
 -89.4%
H
2.2
27.9
|
L
 -95.9%
H
2.2
64.8
|
L
 -98.5%
H
2.2
307
|
L
 -100.0%
H
2.2
14775
|
L
H
2.2
55000
|
L
H
2.2
55000
|
| ICU Medical Inc |
|
3,913.8
|
158.5
|
L
 2.2%
H
155.8
160.3
|
L
 6.8%
H
147.2
160.3
|
L
 9.2%
H
137.4
160.3
|
L
 31.0%
H
115
160.3
|
L
 -5.0%
H
107
175.5
|
L
 -15.2%
H
78.4
212.4
|
L
 -27.2%
H
78.4
282
|
L
 69.0%
H
78.4
321.7
|
| Idexx Laboratories |
|
55,181.3
|
691.1
|
L
 -0.8%
H
688.7
703.5
|
L
 -2.7%
H
681
719.9
|
L
 -1.3%
H
661.9
726.4
|
L
 8.5%
H
622.1
770.0
|
L
 61.7%
H
356.3
770.0
|
L
 41.4%
H
356.3
770.0
|
L
 39.2%
H
317.1
770.0
|
L
 953.8%
H
63.5
770.0
|
| Inspira Tech Oxy B.H.N. Ltd |
|
29.8
|
0.8
|
L
 6.4%
H
0.8
0.9
|
L
 -6.7%
H
0.8
1.0
|
L
 -18.6%
H
0.8
1.1
|
L
 -26.6%
H
0.8
1.2
|
L
 -24.6%
H
0.4
1.7
|
L
 -33.6%
H
0.4
2.5
|
L
H
0.4
9.6
|
L
H
0.4
9.6
|
| Intercure Ltd |
|
51.4
|
0.9
|
L
 1.1%
H
0.9
1.0
|
L
H
0.9
1.0
|
L
 -30.9%
H
0.7
1.3
|
L
 -36.9%
H
0.7
1.5
|
L
 -45.4%
H
0.7
1.8
|
L
 -75.6%
H
0.7
4.0
|
L
 -83.6%
H
0.7
12.7
|
L
H
0.7
19.4
|
| Inogen Inc |
|
168.9
|
6.2
|
L
 -2.2%
H
6.2
6.5
|
L
 -4.3%
H
6.1
6.5
|
L
 -7.3%
H
6
7.5
|
L
 -26.7%
H
6
9.1
|
L
 -44.4%
H
5.7
12.9
|
L
 -72.5%
H
4.1
26.1
|
L
 -86.6%
H
4.1
82.4
|
L
 -82.8%
H
4.1
287.8
|
| Inmode Ltd |
|
890.0
|
14.1
|
L
 -0.3%
H
14.0
14.2
|
L
 0.3%
H
13.7
14.2
|
L
 -2.0%
H
13.7
15.7
|
L
 -12.1%
H
13.7
16.1
|
L
 -17.0%
H
13.1
19.8
|
L
 -59.0%
H
13.1
48.3
|
L
 -51.9%
H
13.1
99.3
|
L
H
6.5
99.3
|
| NAYA Biosciences |
|
26.6
|
1.8
|
L
 -12.4%
H
1.7
2.0
|
L
 117.3%
H
0.8
4.6
|
L
 91.3%
H
0.7
4.6
|
L
 -59.3%
H
0.7
5.8
|
L
 -98.7%
H
0.7
144.2
|
L
 -99.9%
H
0.7
4721.5
|
L
 -100.0%
H
0.7
70848
|
L
 -100.0%
H
0.7
141926.4
|
| IRIDEX Corp |
|
25.6
|
1.5
|
L
 -4.5%
H
1.4
1.7
|
L
 12.9%
H
1.3
1.7
|
L
 49%
H
1
1.7
|
L
 38.0%
H
0.9
1.7
|
L
 -9.7%
H
0.8
1.7
|
L
 -34.4%
H
0.8
3.7
|
L
 -72.4%
H
0.8
9.7
|
L
 -83.5%
H
0.8
16.6
|
| Iradimed Corp |
|
1,321.6
|
103.9
|
L
 0.7%
H
102.8
104.9
|
L
 2.3%
H
100.3
104.9
|
L
 6.9%
H
90.9
104.9
|
L
 37.6%
H
75.6
104.9
|
L
 72.2%
H
47.5
104.9
|
L
 196.8%
H
33.5
104.9
|
L
 349.5%
H
21.7
104.9
|
L
 396.6%
H
7.9
104.9
|
| iRhythm Tech Inc |
|
5,309.4
|
164.8
|
L
 0.7%
H
162.4
165.9
|
L
 1.0%
H
160.8
174.4
|
L
 -5.4%
H
149.9
191.4
|
L
 -7.5%
H
149.9
212
|
L
 51.6%
H
92.5
212
|
L
 65.0%
H
55.9
212
|
L
 -34.6%
H
41.7
286.2
|
L
H
22.2
286.2
|
| Intuitive Surgical |
|
186,397.6
|
525.8
|
L
 0.4%
H
522.7
532
|
L
 -3.8%
H
518.6
553.7
|
L
 -8.2%
H
518.6
603.9
|
L
 13.6%
H
518.6
603.9
|
L
 -13.0%
H
425
616
|
L
 104.8%
H
222.7
616
|
L
 97.5%
H
180.1
616
|
L
 751.8%
H
55.8
616
|
| Kewaunee Scientific Corp |
|
113.6
|
39.6
|
L
 1.9%
H
39.1
39.6
|
L
 5.7%
H
37.5
41.2
|
L
 3.5%
H
37.1
41.2
|
L
 -13.9%
H
37.0
46.6
|
L
 -36.4%
H
30.3
71.3
|
L
 135.8%
H
14.6
71.3
|
L
 213.6%
H
11.4
71.3
|
L
 139.2%
H
7.0
71.3
|
| OrthoPediatrics corp |
|
463.7
|
18.5
|
L
 -0.8%
H
18.4
19.1
|
L
 0.3%
H
17.9
19.3
|
L
 8.3%
H
16.9
20.3
|
L
 3.3%
H
15.9
20.3
|
L
 -32.1%
H
15.3
27.5
|
L
 -60.6%
H
15.3
53.5
|
L
 -56.6%
H
15.3
73.9
|
L
H
14
73.9
|
| KORU Medical Systems Inc |
|
263.1
|
5.7
|
L
 -0.4%
H
5.6
5.8
|
L
 2.0%
H
5.4
5.9
|
L
 -2.1%
H
5.1
6.6
|
L
 35.6%
H
3.7
6.6
|
L
 37.2%
H
1.9
6.6
|
L
 46.0%
H
1.9
6.6
|
L
 10.1%
H
1.8
6.6
|
L
 1252.4%
H
0.3
12.8
|
| Standard BioTools Inc |
|
619.2
|
1.6
|
L
 -1.8%
H
1.6
1.7
|
L
 1.3%
H
1.5
1.7
|
L
 -1.2%
H
1.2
1.7
|
L
 22.0%
H
1.1
1.7
|
L
 -14.4%
H
0.9
1.9
|
L
 -18.3%
H
0.9
3.2
|
L
 -73.9%
H
0.9
7.5
|
L
 -75.4%
H
0.9
14.9
|
| LivaNova PLC |
|
3,488.2
|
63.9
|
L
 1.0%
H
63.2
64.8
|
L
 5.0%
H
60.8
64.8
|
L
 1.7%
H
60.4
65.4
|
L
 16.8%
H
48.8
65.6
|
L
 29.8%
H
32.5
65.6
|
L
 12.4%
H
32.5
65.6
|
L
 -2.9%
H
32.5
93.9
|
L
 22.6%
H
32.5
131.5
|
| Lemaitre Vascular Inc |
|
1,945.1
|
85.7
|
L
 -1.4%
H
85.7
88.2
|
L
 0.3%
H
84.3
88.4
|
L
 0.9%
H
79.4
88.4
|
L
 -4.5%
H
79.4
92.3
|
L
 -14.0%
H
71.4
105.6
|
L
 81.8%
H
44.3
109.6
|
L
 91.5%
H
38.3
109.6
|
L
 496.2%
H
12.0
109.6
|
| LENSAR Inc |
|
147.8
|
12.4
|
L
 0.5%
H
12.3
12.4
|
L
 4.2%
H
11.8
12.4
|
L
 3%
H
11.2
12.4
|
L
 0.9%
H
9.5
12.7
|
L
 51.4%
H
8.1
17.3
|
L
 354.8%
H
1.8
17.3
|
L
 93.3%
H
1.8
17.3
|
L
H
1.8
17.3
|
| Lantheus Holdings Inc |
|
4,454.8
|
67.2
|
L
 1.1%
H
66.0
67.9
|
L
 2.4%
H
63.4
67.9
|
L
 1.9%
H
63.4
70.3
|
L
 16.4%
H
50.2
70.3
|
L
 -28.6%
H
47.3
111.3
|
L
 25.8%
H
47.3
126.9
|
L
 336.2%
H
15.3
126.9
|
L
 2653.3%
H
1.8
126.9
|
| Lucid Diagnostics Inc |
|
140.3
|
1.1
|
L
 -5.3%
H
1.1
1.2
|
L
 -13.7%
H
1.1
1.6
|
L
 -4.5%
H
1.0
1.6
|
L
 -11.6%
H
1.0
1.6
|
L
 25.9%
H
0.8
1.8
|
L
 -18.9%
H
0.6
1.9
|
L
H
0.6
13.5
|
L
H
0.6
13.5
|
| Pulmonx Corp |
|
78.8
|
1.9
|
L
 2.7%
H
1.9
2.0
|
L
 -4.5%
H
1.7
2
|
L
 -26.5%
H
1.7
2.6
|
L
 18.6%
H
1.3
2.9
|
L
 -69.1%
H
1.3
9.4
|
L
 -77.9%
H
1.3
14.8
|
L
 -97.0%
H
1.3
68.8
|
L
H
1.3
69.5
|
| Masimo Corp |
|
7,731.0
|
143.9
|
L
 -1.6%
H
142.1
146.7
|
L
 4.0%
H
137.7
148.8
|
L
 7.4%
H
125.9
148.8
|
L
 -3.0%
H
125.9
157.7
|
L
 -18.3%
H
125.9
194.9
|
L
 -14.6%
H
75.2
198
|
L
 -44.9%
H
75.2
305.2
|
L
 294.0%
H
33.0
305.2
|
| 908 Devices Inc |
|
253.4
|
7
|
L
 4.0%
H
6.7
7.0
|
L
 28.7%
H
5.4
7.0
|
L
 19.9%
H
5.0
7.0
|
L
 -20.2%
H
5.0
9.2
|
L
 131.0%
H
1.9
9.3
|
L
 -23.7%
H
1.8
12.5
|
L
 -88.8%
H
1.8
79.6
|
L
H
1.8
79.6
|
| Mimedx Grp Inc |
|
802.7
|
5.4
|
L
 1.7%
H
5.3
5.5
|
L
 -4.8%
H
5.1
5.9
|
L
 -23.1%
H
5.1
7.2
|
L
 -19.6%
H
5.1
8.0
|
L
 -40.7%
H
5.1
9.3
|
L
 58.9%
H
3.1
10.1
|
L
 -38.5%
H
2.4
16.0
|
L
 -36.3%
H
1.0
18.3
|
| Mesa Laboratories Inc |
|
477.3
|
86.4
|
L
H
86.1
88.2
|
L
 -0.4%
H
82.3
89.4
|
L
 6.7%
H
77.0
90.0
|
L
 9.5%
H
69.5
90.0
|
L
 -41.1%
H
55.5
155.1
|
L
 -56.1%
H
55.5
206.4
|
L
 -70.0%
H
55.5
333.4
|
L
 -4.5%
H
55.5
333.4
|
| Merit Medical Systems Inc |
|
4,944.2
|
83.4
|
L
 -0.1%
H
83.1
84.6
|
L
 2.0%
H
79.7
84.6
|
L
 -4.9%
H
79.7
94.8
|
L
 -0.9%
H
79.7
94.8
|
L
 -20.1%
H
78.1
111.5
|
L
 18.7%
H
62.6
111.5
|
L
 46.8%
H
50.5
111.5
|
L
 421.2%
H
15.6
111.5
|
| Modular Medical Inc |
|
36.5
|
0.5
|
L
 2.2%
H
0.5
0.5
|
L
 2.2%
H
0.5
0.5
|
L
 38.2%
H
0.3
0.5
|
L
 -21.7%
H
0.3
0.6
|
L
 -60.5%
H
0.3
1.4
|
L
 -83.3%
H
0.3
3.8
|
L
 -96.7%
H
0.3
19.5
|
L
 -42.0%
H
0.3
19.5
|
| Myriad Genetics Inc |
|
564.9
|
6.1
|
L
 3.8%
H
5.8
6.2
|
L
 -0.8%
H
5.5
6.2
|
L
 -7.5%
H
5.5
7.2
|
L
 -24.8%
H
5.5
8.5
|
L
 -51.8%
H
3.8
15.5
|
L
 -70.2%
H
3.8
29.3
|
L
 -77.3%
H
3.8
37.0
|
L
 -84.3%
H
3.8
50.4
|
| MDxHealth SA (ADR) |
|
-
|
4.2
|
L
 7.0%
H
3.9
4.3
|
L
 16.3%
H
3.5
4.3
|
L
 31.8%
H
3
4.3
|
L
 2.5%
H
2.8
5.3
|
L
 108.5%
H
1.4
5.3
|
L
 -37.6%
H
1.4
7.6
|
L
H
1.4
13.2
|
L
H
1.4
13.2
|
| ENvue Medical Inc |
|
1.3
|
1.2
|
L
 -7.9%
H
1.1
1.2
|
L
 -31.8%
H
1.1
1.6
|
L
 -61.3%
H
1.1
3.2
|
L
 -80.3%
H
1.1
6
|
L
 -97.9%
H
0.7
162.5
|
L
 -99.8%
H
0.7
836
|
L
 -100.0%
H
0.7
9218
|
L
 -100.0%
H
0.7
18700
|
| ENDRA Life Sciences Inc |
|
5.5
|
4.7
|
L
 8.8%
H
4.4
4.8
|
L
 2.2%
H
4.2
4.8
|
L
 -9.1%
H
4.2
5.3
|
L
 -23.5%
H
4.1
7.0
|
L
 -23.7%
H
2.9
12.0
|
L
 -98.0%
H
0.0
234
|
L
 -99.8%
H
0.0
3100
|
L
H
0.0
5880
|
| Neogen Corp |
|
2,160.0
|
9.9
|
L
 0.6%
H
9.7
10.1
|
L
 5.8%
H
8.9
10.1
|
L
 37.9%
H
6.9
10.3
|
L
 68.3%
H
5.4
10.3
|
L
 -15.4%
H
3.9
12.1
|
L
 -49.4%
H
3.9
24.1
|
L
 -76.2%
H
3.9
48.9
|
L
 -49.1%
H
3.9
48.9
|
| Nephros Inc |
|
49.5
|
4.7
|
L
 2.2%
H
4.6
4.7
|
L
 5.7%
H
4.2
5.1
|
L
 -7.4%
H
4.2
5.5
|
L
 -3.9%
H
3.7
6.4
|
L
 196.8%
H
1.4
6.4
|
L
 247.8%
H
1.0
6.4
|
L
 -41.7%
H
0.9
11.7
|
L
 29.4%
H
0.9
11.7
|
| NeuroOne Medical Tech Corp |
|
43.9
|
0.9
|
L
 -3.3%
H
0.9
0.9
|
L
H
0.9
0.9
|
L
 19.2%
H
0.7
1.0
|
L
 6.1%
H
0.6
1.0
|
L
 -14.7%
H
0.4
1.4
|
L
 -34.1%
H
0.4
2.2
|
L
 -88.2%
H
0.4
13.5
|
L
H
0.4
30
|
| Nano X Imaging Ltd |
|
203.3
|
3.1
|
L
 3.0%
H
3.0
3.2
|
L
 3.0%
H
2.9
3.2
|
L
 4.0%
H
2.8
3.2
|
L
 -23.8%
H
2.8
4.7
|
L
 -62.9%
H
2.8
9.2
|
L
 -65.0%
H
2.8
22.7
|
L
 -95.3%
H
2.8
94.8
|
L
H
2.8
94.8
|
| NeuroPace Inc |
|
567.6
|
17.0
|
L
 0.6%
H
17
17.4
|
L
 1.7%
H
16.2
17.6
|
L
 2.7%
H
15.0
17.9
|
L
 57.9%
H
9.2
17.9
|
L
 30.5%
H
7.6
19.0
|
L
 471.8%
H
2.9
19.0
|
L
H
1.2
27.4
|
L
H
1.2
27.4
|
| InspireMD Inc |
|
72.5
|
1.7
|
L
 5.6%
H
1.6
1.7
|
L
 7.6%
H
1.5
1.7
|
L
 -14.1%
H
1.5
2.2
|
L
 -27.2%
H
1.5
2.4
|
L
 -41.8%
H
1.5
3.8
|
L
 52.7%
H
1.0
3.9
|
L
 -84.2%
H
0.8
22.2
|
L
 -100.0%
H
0.8
622059.4
|
| Nortech Systems Inc |
|
24.4
|
8.8
|
L
 4.9%
H
8.4
8.8
|
L
 8.4%
H
8
8.8
|
L
 23.4%
H
7.1
8.8
|
L
 -10.2%
H
6.5
10
|
L
 -13.6%
H
6.5
12.4
|
L
 -34.8%
H
6.5
19.2
|
L
 16.0%
H
5.5
19.6
|
L
 117.9%
H
1.7
19.6
|
| Natera Inc |
|
33,873.6
|
242.9
|
L
 0.1%
H
242.2
250
|
L
 1.6%
H
226.7
250
|
L
 4.7%
H
225.8
256.4
|
L
 30.0%
H
182.2
256.4
|
L
 45.1%
H
125.4
256.4
|
L
 493.8%
H
36.9
256.4
|
L
 102.4%
H
26.1
256.4
|
L
 2731.1%
H
6.5
256.4
|
| Nutriband Inc |
|
55.0
|
4.5
|
L
 1.6%
H
4.4
4.6
|
L
 6.4%
H
4.3
4.7
|
L
 0.7%
H
4.2
6.4
|
L
 -37.9%
H
4.2
8.3
|
L
 -13.2%
H
4.2
11.8
|
L
 31.0%
H
1.5
11.8
|
L
 -60.9%
H
0.9
27.4
|
L
H
0.9
43.5
|
| Nuwellis Inc |
|
1.9
|
2.1
|
L
 14.0%
H
1.9
2.3
|
L
 11.6%
H
1.7
2.9
|
L
 -1.9%
H
1.7
2.9
|
L
 -33.8%
H
1.7
4
|
L
 -95.7%
H
1.7
70.1
|
L
 -100.0%
H
1.7
16008.3
|
L
 -100.0%
H
1.7
1819771.8
|
L
 -100.0%
H
1.7
10000000000
|
| NovoCure Ltd |
|
1,589.0
|
14.2
|
L
 4.7%
H
13.7
14.3
|
L
 3.1%
H
12.8
14.3
|
L
 10.5%
H
12.8
15.2
|
L
 0.4%
H
10.7
15.2
|
L
 -47.4%
H
10.7
27.4
|
L
 -84.0%
H
10.7
95.9
|
L
 -91.7%
H
10.7
232.8
|
L
 -5.7%
H
6.0
232.8
|
| enVVeno Medical Corp |
|
7.2
|
10.9
|
L
H
9.8
11.2
|
L
 -13.6%
H
9.8
12.9
|
L
 -2.5%
H
9.8
13.8
|
L
 -57.1%
H
9.8
27.3
|
L
 -91.1%
H
9.8
196.7
|
L
 -93.6%
H
9.8
244.0
|
L
 -96.4%
H
9.8
398.3
|
L
H
9.8
4935
|
| Nexalin Tech Inc |
|
11.8
|
0.6
|
L
 1.6%
H
0.6
0.7
|
L
 -14.9%
H
0.6
0.7
|
L
 -24.1%
H
0.5
0.8
|
L
 -59.1%
H
0.5
1.7
|
L
 -77.7%
H
0.5
3.9
|
L
 -44.7%
H
0.3
4.5
|
L
H
0.3
4.5
|
L
H
0.3
4.5
|
| Nyxoah SA |
|
206.5
|
4.8
|
L
 1.1%
H
4.8
5
|
L
 -6.3%
H
4.7
5.3
|
L
 -1.0%
H
4.5
5.4
|
L
 -16.2%
H
4.4
6.0
|
L
 -55.7%
H
4.3
11.9
|
L
 -14.3%
H
4
20
|
L
H
4
37
|
L
H
4
37
|
| Nanobiotix (ADR) |
|
1,034.5
|
21.4
|
L
 6.6%
H
21.0
21.4
|
L
 -0.7%
H
19.8
22.2
|
L
 -3.4%
H
19.6
24.0
|
L
 -5.5%
H
14.8
24.0
|
L
 557.9%
H
3.0
30.4
|
L
 389.2%
H
1.8
30.4
|
L
 9.8%
H
1.8
30.4
|
L
H
1.8
30.4
|
| Orchestra BioMed Holdings Inc |
|
233.2
|
4.1
|
L
 1.0%
H
4.1
4.3
|
L
 -7.4%
H
3.9
4.5
|
L
 -5.1%
H
3.9
5
|
L
 6.2%
H
3.5
5.4
|
L
 -20.1%
H
2.2
6.2
|
L
 -59.0%
H
2.2
23.4
|
L
 -66.9%
H
2.2
23.4
|
L
H
2.2
23.4
|
| Orthofix Medical Inc |
|
547.7
|
13.8
|
L
 -0.1%
H
13.7
14.2
|
L
 -3.4%
H
13.3
14.5
|
L
 -10.5%
H
13.3
16.4
|
L
 -12.0%
H
13.3
17.0
|
L
 -24.7%
H
10.2
20.5
|
L
 -32.5%
H
9.6
22.6
|
L
 -68.3%
H
9.6
48.5
|
L
 -64.4%
H
9.6
74.4
|
| Outset Medical Inc |
|
98.0
|
5.4
|
L
 3.9%
H
5.2
5.6
|
L
 -1.5%
H
5
5.7
|
L
 46.0%
H
3.1
6.5
|
L
 -64.6%
H
3.1
15.9
|
L
 -55.4%
H
0.5
22.0
|
L
 -98.7%
H
0.5
458.3
|
L
 -99.3%
H
0.5
915
|
L
H
0.5
1004.4
|
| Organogenesis Holdings Inc (Class A) |
|
507.6
|
4
|
L
 4.2%
H
3.8
4.1
|
L
 3.4%
H
3.6
4.1
|
L
 -28.6%
H
3.6
5.9
|
L
 -1.7%
H
3.6
7.1
|
L
 13.3%
H
2.6
7.1
|
L
 53.3%
H
1.8
7.1
|
L
 -60.0%
H
1.8
24.3
|
L
H
1.8
310.9
|
| Orasure Tech Inc |
|
195.1
|
2.7
|
L
 -2.2%
H
2.7
2.8
|
L
 0.7%
H
2.6
2.8
|
L
 13.8%
H
2.3
2.8
|
L
 -8.4%
H
2.1
3
|
L
 -30.6%
H
2.1
4.2
|
L
 -45.9%
H
2.1
8.5
|
L
 -79.9%
H
2.1
15.9
|
L
 -51.3%
H
2.1
23.0
|
| Pacific Biosciences of California Inc |
|
806.1
|
2.7
|
L
 10.3%
H
2.4
2.7
|
L
 13.1%
H
2.1
2.7
|
L
 45.1%
H
1.7
2.7
|
L
 40.5%
H
1.5
2.7
|
L
 57.1%
H
0.9
2.7
|
L
 -76.4%
H
0.9
14.6
|
L
 -92.6%
H
0.9
53.7
|
L
 -79.4%
H
0.9
53.7
|
| PAVmed Inc |
|
10.1
|
11.0
|
L
 -8.9%
H
10.8
12.7
|
L
 19.5%
H
6.1
28.4
|
L
 18.8%
H
6
28.4
|
L
 -23.8%
H
6
28.4
|
L
 -43.7%
H
6
28.4
|
L
 -94.6%
H
6
280.8
|
L
 -98.9%
H
6
4365
|
L
H
6
6858
|
| Pro-Dex Inc (co) |
|
131.9
|
40.4
|
L
 -1.1%
H
40.3
42.3
|
L
 -1.6%
H
39.6
43.4
|
L
 4.5%
H
36.6
47.4
|
L
 55.0%
H
25.6
47.4
|
L
 -8.8%
H
23.5
70.3
|
L
 136.1%
H
14.5
70.3
|
L
 27.3%
H
12.4
70.3
|
L
 1665.1%
H
2.3
70.3
|
| Pulse Biosciences Inc |
|
986.0
|
14.6
|
L
 1.3%
H
14.3
15.0
|
L
 1.8%
H
13.8
15.0
|
L
 -4.7%
H
13.2
16.0
|
L
 -19.5%
H
12.6
18.4
|
L
 -25.7%
H
12.6
25
|
L
 410.5%
H
2.4
25
|
L
 -49.4%
H
1.2
45.8
|
L
H
1.2
45.8
|
| Axe Compute Inc |
|
20.3
|
6.0
|
L
 -4.2%
H
5.8
6.3
|
L
 -12.7%
H
5.3
9
|
L
 -11.7%
H
5.3
9
|
L
 -36.4%
H
3.9
10.1
|
L
 -68.6%
H
3.9
39
|
L
 -95.2%
H
3.9
208.2
|
L
 -98.5%
H
3.9
690
|
L
 -100.0%
H
3.9
285000
|
| Precision Optics Corp Inc |
|
39.0
|
5.1
|
L
 0.8%
H
4.9
5.2
|
L
 16.3%
H
4.3
5.3
|
L
 24.0%
H
4.0
5.3
|
L
 18.0%
H
4.0
5.3
|
L
 0.6%
H
3.8
5.3
|
L
 -14.2%
H
3.5
7.2
|
L
H
3.5
7.9
|
L
H
3.5
7.9
|
| Insulet |
|
19,697.1
|
280
|
L
 -1.7%
H
275.1
287.4
|
L
 -1.0%
H
275.1
289.3
|
L
 -3.3%
H
275.1
299.8
|
L
 -14.9%
H
275.1
354.9
|
L
 1.4%
H
230.1
354.9
|
L
 -4.9%
H
125.8
354.9
|
L
 -3.7%
H
125.8
354.9
|
L
 736.8%
H
23.9
354.9
|
| Procept BioRobotics Corp |
|
1,717.1
|
30.7
|
L
 -0.7%
H
30.6
32.1
|
L
 -2.0%
H
29.6
32.1
|
L
 -4.2%
H
29.6
35.4
|
L
 -11.2%
H
27.8
38.1
|
L
 -55.9%
H
27.8
76.4
|
L
 -20.4%
H
24.8
103.8
|
L
H
15.4
103.8
|
L
H
15.4
103.8
|
| Prenetics Global Ltd (Class A) |
|
318.1
|
18.9
|
L
 15.5%
H
15.8
19.0
|
L
 20.2%
H
14.1
19.0
|
L
 8.1%
H
14.1
19.0
|
L
 14.3%
H
11.4
19.0
|
L
 215%
H
3.1
19.0
|
L
 -18.7%
H
2.9
24.8
|
L
H
2.9
131.3
|
L
H
2.9
131.3
|
| Profound Medical Corp |
|
280.5
|
7.7
|
L
 -3.4%
H
7.7
8.3
|
L
 1.4%
H
7.5
8.6
|
L
 1.3%
H
7
9.0
|
L
 31.9%
H
5.2
9.0
|
L
 5.6%
H
3.8
9.0
|
L
 -35.5%
H
3.8
15.5
|
L
 -70.7%
H
3.1
29.0
|
L
H
0.0
29.0
|
| QuidelOrtho Corporation |
|
2,076.0
|
30.6
|
L
 3.9%
H
29.8
31.4
|
L
 -11.0%
H
27.2
35.6
|
L
 5.6%
H
27.2
35.6
|
L
 2.5%
H
19.5
35.6
|
L
 -30.1%
H
19.5
46.2
|
L
 -65.3%
H
19.5
98.7
|
L
 -86.0%
H
19.5
265
|
L
 84.2%
H
13.2
306.7
|
| Quanterix Corp |
|
337.3
|
7.2
|
L
 2.4%
H
7.1
7.5
|
L
 -1.8%
H
6.8
8.1
|
L
 9.6%
H
6.2
8.8
|
L
 19.1%
H
4.5
8.8
|
L
 -25.7%
H
4.1
10.3
|
L
 -49.5%
H
4.1
29.7
|
L
 -91.0%
H
4.1
92.6
|
L
H
4.1
92.6
|
| AVITA Medical Inc |
|
125.9
|
4.1
|
L
 6.2%
H
3.8
4.2
|
L
 17.3%
H
3.4
4.2
|
L
 19.4%
H
3.2
4.2
|
L
 0.2%
H
3.2
4.2
|
L
 -52.7%
H
3.2
11.3
|
L
 -52.1%
H
3.2
21.7
|
L
 -84.7%
H
3.2
28.5
|
L
 -41.4%
H
3.2
55.4
|
| Rockwell Medical Inc |
|
44.1
|
1.1
|
L
 -8.9%
H
1.1
1.2
|
L
 16.7%
H
1.0
1.3
|
L
 31.8%
H
0.8
1.3
|
L
 -5.1%
H
0.8
1.3
|
L
 -48.9%
H
0.8
2.3
|
L
 -42.6%
H
0.8
6.2
|
L
 -92.6%
H
0.8
21.8
|
L
 -98.6%
H
0.8
116.4
|
| Vyome Holdings Inc |
|
16.5
|
2.9
|
L
 9.0%
H
2.7
3.0
|
L
 -3.3%
H
2.7
3.3
|
L
 -20.7%
H
2.7
3.9
|
L
 -46.3%
H
2.7
6.6
|
L
 -35.5%
H
0.3
12.9
|
L
 -99.3%
H
0.3
1299.2
|
L
 -100.0%
H
0.3
65859
|
L
H
0.3
1381560
|
| Rewalk Robotics Ltd |
|
42.1
|
0.7
|
L
 -2.8%
H
0.7
0.7
|
L
 6.1%
H
0.7
0.8
|
L
 7.7%
H
0.6
0.8
|
L
 2.9%
H
0.5
0.8
|
L
 -46.2%
H
0.5
1.3
|
L
 -88.5%
H
0.5
9.1
|
L
 -96.2%
H
0.5
42
|
L
 -100.0%
H
0.5
2135
|
| Sanmina Corp |
|
9,794.8
|
179.5
|
L
 -0.9%
H
175.0
185.3
|
L
 7.5%
H
169.6
185.3
|
L
 18.5%
H
144
185.3
|
L
 38.4%
H
124.4
185.3
|
L
 113.3%
H
63.7
185.3
|
L
 196.3%
H
43.4
185.3
|
L
 426.4%
H
30.6
185.3
|
L
 957.8%
H
17.0
185.3
|
| Sight Sciences Inc |
|
339.4
|
6.4
|
L
 0.6%
H
6.1
6.7
|
L
 -6.8%
H
6.0
6.9
|
L
 -24.0%
H
6.0
9.2
|
L
 24.4%
H
4.9
9.2
|
L
 122.2%
H
2.0
9.2
|
L
 -48.6%
H
1.0
13.3
|
L
H
1.0
42.6
|
L
H
1.0
42.6
|
| Sotera Health Co |
|
5,369.4
|
18.9
|
L
 -0.4%
H
18.9
19.2
|
L
 -1.5%
H
18.6
19.4
|
L
 10.1%
H
17.1
19.9
|
L
 13.7%
H
15.0
19.9
|
L
 42%
H
9.5
19.9
|
L
 11.7%
H
9.5
19.9
|
L
 -27.5%
H
5.8
30.4
|
L
H
5.8
30.4
|
| SI-BONE Inc |
|
734.2
|
16.9
|
L
 -0.4%
H
16.9
17.3
|
L
 -3.0%
H
16.7
17.7
|
L
 -17.0%
H
16.7
21.9
|
L
 9.0%
H
14.5
21.9
|
L
 -2.1%
H
12.5
21.9
|
L
 -1.7%
H
11.7
29.5
|
L
 -44.7%
H
11.1
37.2
|
L
H
7.2
37.2
|
| SINTX Tech Inc |
|
13.7
|
3.6
|
L
 -0.3%
H
3.5
3.6
|
L
 -3.5%
H
3.5
3.8
|
L
 -1.4%
H
3.5
4.1
|
L
 2.3%
H
3.0
4.5
|
L
 11.3%
H
1.7
7.4
|
L
 -99.8%
H
0.1
2428
|
L
 -100.0%
H
0.1
68800
|
L
 -100.0%
H
0.1
26064000
|
| Beauty Health Co (Class A) |
|
198.9
|
1.6
|
L
 1.3%
H
1.5
1.6
|
L
 1.3%
H
1.4
1.6
|
L
 2.0%
H
1.4
1.6
|
L
 16.4%
H
1.2
1.7
|
L
 -13.8%
H
0.8
2.7
|
L
 -86.1%
H
0.8
13.9
|
L
 -86.0%
H
0.8
30.2
|
L
H
0.8
30.2
|
| Sanara MedTech Inc |
|
198.8
|
22.3
|
L
 -2.4%
H
22.2
23.0
|
L
 -3.9%
H
21.7
24.1
|
L
 -8.1%
H
21.7
26.0
|
L
 -23.7%
H
18.9
31.7
|
L
 -34.6%
H
18.9
38.7
|
L
 -53.6%
H
18.9
50.2
|
L
 -47.0%
H
17.4
50.2
|
L
 304.5%
H
2
75
|
| Sensus Healthcare Inc |
|
81.6
|
5.0
|
L
 0.2%
H
4.9
5.2
|
L
 -0.2%
H
4.9
5.3
|
L
 29.8%
H
3.7
5.5
|
L
 53.9%
H
3.1
5.5
|
L
 -27.3%
H
3.0
9.1
|
L
 -45.7%
H
1.8
9.3
|
L
 31.8%
H
1.8
15.3
|
L
H
1.8
15.3
|
| STRATA Skin Sciences Inc |
|
7.7
|
1.3
|
L
 1.6%
H
1.3
1.3
|
L
 1.6%
H
1.3
1.4
|
L
 9.2%
H
1.2
1.5
|
L
 -23.1%
H
1.2
2.3
|
L
 -54.9%
H
1.2
3.9
|
L
 -86.0%
H
1.2
41
|
L
 -93.0%
H
1.2
41
|
L
 -97.6%
H
1.2
76.5
|
| Staar Surgical Co. |
|
981.9
|
19.9
|
L
 -3.5%
H
19.6
20.8
|
L
 -8.9%
H
19.4
21.7
|
L
 -20.9%
H
19.4
25.7
|
L
 -25.5%
H
19.4
28.4
|
L
 -13.6%
H
13.5
30.8
|
L
 -71.8%
H
13.5
81.8
|
L
 -77.8%
H
13.5
163.1
|
L
 189.5%
H
5.0
163.1
|
| Neuronetics Inc |
|
150.7
|
2.2
|
L
 10.6%
H
2.0
2.2
|
L
 24.3%
H
1.8
2.2
|
L
 57.1%
H
1.3
2.2
|
L
 -23.6%
H
1.3
3.2
|
L
 -1.8%
H
1.3
5.9
|
L
 -63.5%
H
0.5
6.6
|
L
 -88.1%
H
0.5
22.4
|
L
H
0.5
39.4
|
| Star Equity Holdings Inc |
|
34.4
|
10.7
|
L
 0.3%
H
10.4
10.7
|
L
 -0.1%
H
10.2
11.0
|
L
 -2.7%
H
10.2
11.5
|
L
 -3.3%
H
9.3
11.5
|
L
 381.9%
H
1.7
12.0
|
L
 131.0%
H
1.7
12.0
|
L
 -43.8%
H
1.7
27
|
L
 -95.6%
H
1.7
307.5
|
| Sharps Tech Inc |
|
63.8
|
2.2
|
L
 -2.2%
H
2.1
2.3
|
L
 0.9%
H
2.1
2.4
|
L
 -0.9%
H
1.7
2.6
|
L
 -56.4%
H
1.7
5.5
|
L
 -99.6%
H
0.0
573
|
L
 -100.0%
H
0.0
13464
|
L
H
0.0
23892
|
L
H
0.0
23892
|
| Tactile Systems Tech Inc |
|
666.9
|
29.9
|
L
 -2.1%
H
29.7
30.9
|
L
 -0.5%
H
29.3
31.4
|
L
 3.3%
H
26.9
31.4
|
L
 102.3%
H
14.6
31.4
|
L
 68.2%
H
8.6
31.4
|
L
 141.8%
H
8.6
31.4
|
L
 -42.4%
H
6.3
64.5
|
L
H
6.3
76.6
|
| TELA Bio Inc |
|
42.7
|
1.0
|
L
 -2.0%
H
1.0
1.0
|
L
 -5.0%
H
0.9
1.0
|
L
 -15.0%
H
0.9
1.2
|
L
 -36.4%
H
0.9
1.5
|
L
 -63.5%
H
0.9
3.0
|
L
 -92%
H
0.9
12.3
|
L
 -93.4%
H
0.9
18
|
L
H
0.9
23.5
|
| Tivic Health Systems Inc |
|
3.2
|
1.3
|
L
 0.8%
H
1.2
1.3
|
L
 2.4%
H
1.2
1.3
|
L
 -26.4%
H
1.2
2.5
|
L
 -56.6%
H
1.2
2.9
|
L
 -73.6%
H
1.2
15.6
|
L
 -99.9%
H
1.2
1445
|
L
H
1.2
11050
|
L
H
1.2
11050
|
| Treace Medical Concepts Inc |
|
171.4
|
2.7
|
L
 3.1%
H
2.6
2.8
|
L
 -0.4%
H
2.6
2.8
|
L
 4.7%
H
2.4
3.1
|
L
 -61.3%
H
2.4
7.1
|
L
 -71.0%
H
2.4
10.8
|
L
 -89.6%
H
2.4
28.0
|
L
H
2.4
37.2
|
L
H
2.4
37.2
|
| Transmedics Grp Inc |
|
4,719.1
|
138.1
|
L
 3.2%
H
132.0
141
|
L
 -2.7%
H
132.0
149.2
|
L
 8.2%
H
120.2
151.9
|
L
 15.0%
H
111.0
156
|
L
 143.4%
H
56.5
156
|
L
 114.7%
H
36.4
177.4
|
L
 475.4%
H
10
177.4
|
L
H
10
177.4
|
| Tandem Diabetes Care Inc |
|
1,396.1
|
20.6
|
L
 -0.7%
H
20.4
21.6
|
L
 -1.3%
H
19.6
22.0
|
L
 -6.7%
H
19.6
24.1
|
L
 33.8%
H
13.2
24.5
|
L
 -41.7%
H
10.0
37.9
|
L
 -51.8%
H
10.0
53.7
|
L
 -78.2%
H
10.0
155.9
|
L
 -75.2%
H
2.1
155.9
|
| Trinity Biotech PLC (ADR) |
|
14.8
|
0.8
|
L
 12.9%
H
0.7
0.8
|
L
 12.9%
H
0.7
0.8
|
L
 -12.2%
H
0.7
1.8
|
L
 -17.7%
H
0.7
1.8
|
L
 -96.1%
H
0.7
86
|
L
 -99.9%
H
0.7
775
|
L
 -100.0%
H
0.7
4262.5
|
L
 -100.0%
H
0.7
8550
|
| Utah Medical Products Inc |
|
198.9
|
62.1
|
L
 -1.1%
H
61.7
64.0
|
L
 5.4%
H
59.4
64.0
|
L
 9.7%
H
55.8
64.0
|
L
 2.7%
H
53.7
64.0
|
L
 -1.1%
H
51.3
65.6
|
L
 -34.1%
H
51.3
100.6
|
L
 -28.1%
H
51.3
133.9
|
L
 10.1%
H
51.3
133.9
|
| Vivani Medical Inc |
|
107.2
|
1.5
|
L
 -2.7%
H
1.4
1.6
|
L
 15.8%
H
1.2
1.6
|
L
 5.8%
H
1.2
1.6
|
L
 -12.5%
H
1.2
1.8
|
L
 22.5%
H
0.9
1.9
|
L
 21.5%
H
0.8
7.8
|
L
 -74.0%
H
0.8
60
|
L
 -98.5%
H
0.8
166.3
|
| Veracyte Inc |
|
3,462.4
|
43.8
|
L
 1.2%
H
43.0
45.6
|
L
 3.2%
H
40.3
45.6
|
L
 2.1%
H
40.3
46.8
|
L
 21.3%
H
34.4
50.7
|
L
 0.5%
H
22.6
50.7
|
L
 76.0%
H
18.6
50.7
|
L
 -18.8%
H
14.9
86.0
|
L
 611.0%
H
4.2
86.0
|
| Venus Concept Inc |
|
3.0
|
1.6
|
L
 -14.3%
H
1.6
1.8
|
L
 12.5%
H
1.4
12.9
|
L
 -15.6%
H
1.4
12.9
|
L
 -29.3%
H
1.4
12.9
|
L
 376.5%
H
0.3
14.5
|
L
 -66.4%
H
0.3
14.5
|
L
 -95.3%
H
0.3
51.6
|
L
H
0.3
2688.8
|
| Varex Imaging Corp |
|
602.0
|
14.4
|
L
 1.5%
H
14.2
14.6
|
L
 5.0%
H
13.4
14.6
|
L
 16.8%
H
11.5
14.6
|
L
 23.3%
H
9.8
14.6
|
L
 3.2%
H
6.8
15.5
|
L
 -32.9%
H
6.8
23.9
|
L
 -27.2%
H
6.8
32.7
|
L
H
6.8
43.8
|
| Vivos Therapeutics Inc |
|
20.9
|
1.8
|
L
H
1.8
1.9
|
L
 -12.4%
H
1.8
2.2
|
L
 -7.1%
H
1.8
2.7
|
L
 -33.7%
H
1.8
3.1
|
L
 -67.4%
H
1.8
8.0
|
L
 -94.6%
H
1.8
48.8
|
L
 -99.0%
H
1.8
271.5
|
L
H
1.8
360.3
|
| Wrap Tech Inc |
|
133.0
|
2.6
|
L
 4.5%
H
2.5
2.6
|
L
 -14.9%
H
2.4
3.2
|
L
 13.2%
H
2.1
3.2
|
L
H
1.9
3.2
|
L
 29%
H
1.2
3.2
|
L
 7.9%
H
1.0
7.0
|
L
 -49.0%
H
1.0
9.8
|
L
H
1.0
14.4
|
| Beyond Air Inc |
|
15.1
|
1.8
|
L
 -2.8%
H
1.7
1.9
|
L
 -5.9%
H
1.4
2.3
|
L
 94.5%
H
0.7
2.7
|
L
 -27.2%
H
0.7
2.7
|
L
 -79.8%
H
0.7
10.4
|
L
 -98.7%
H
0.7
154.8
|
L
 -98.5%
H
0.7
328.2
|
L
H
0.7
900
|
| DENTSPLY Sirona Inc |
|
2,594.2
|
13
|
L
 2.0%
H
12.6
13.0
|
L
 5.3%
H
12.0
13.0
|
L
 16.0%
H
11.0
13.0
|
L
 0.2%
H
9.9
13.3
|
L
 -31.4%
H
9.9
20.6
|
L
 -64.8%
H
9.9
43.2
|
L
 -77.4%
H
9.9
69.5
|
L
 -76.9%
H
9.9
69.5
|
| X.T.L. Biopharma Ltd (ADR) |
|
9.9
|
1.1
|
L
 8.3%
H
0.9
1.1
|
L
 11.7%
H
0.8
1.1
|
L
 -67.9%
H
0.5
3.3
|
L
 -79.7%
H
0.5
5.2
|
L
 -85.5%
H
0.5
10.3
|
L
 -80.7%
H
0.5
20.0
|
L
 -92.5%
H
0.5
26.8
|
L
 -96.2%
H
0.5
31.8
|
| Jin Medical Intl Ltd |
|
20.4
|
0.1
|
L
H
0.1
0.1
|
L
 -18.8%
H
0.1
0.2
|
L
 -38.1%
H
0.1
0.3
|
L
 -62.9%
H
0.1
0.4
|
L
 -85.2%
H
0.1
1.0
|
L
H
0.1
509.9
|
L
H
0.1
509.9
|
L
H
0.1
509.9
|
| HeartBeam Inc |
|
64.4
|
1.9
|
L
 0.5%
H
1.9
2.0
|
L
 -18.3%
H
1.9
2.4
|
L
 -39.7%
H
1.9
3.2
|
L
 14.0%
H
0.5
4
|
L
 -12.6%
H
0.5
4
|
L
 18.4%
H
0.5
4
|
L
 18.4%
H
0.5
4
|
L
 18.4%
H
0.5
4
|
| Incannex Healthcare Ltd (ADR) |
|
124.6
|
0.4
|
L
H
0.4
0.4
|
L
 -7.7%
H
0.3
0.4
|
L
 -18.2%
H
0.3
0.5
|
L
H
0.3
0.5
|
L
 -81.1%
H
0.1
2.3
|
L
 -93.4%
H
0.1
5.3
|
L
 -93.4%
H
0.1
5.3
|
L
 -93.4%
H
0.1
5.3
|
| Rewalk Robotics Ltd |
|
12.6
|
0.7
|
L
 -1.4%
H
0.7
0.7
|
L
 4.6%
H
0.7
0.8
|
L
 6.2%
H
0.6
0.8
|
L
 1.5%
H
0.5
0.8
|
L
 -57.4%
H
0.5
3.0
|
L
 -88.7%
H
0.5
9.1
|
L
 -96.3%
H
0.5
42
|
L
 -100.0%
H
0.5
2135
|
| Work Medical Tech Grp Ltd |
|
2.5
|
2.1
|
L
 0.5%
H
2.0
2.1
|
L
 -19.8%
H
1.9
2.6
|
L
 -61.1%
H
1.9
5.9
|
L
 -99.5%
H
1.9
836
|
L
 -100%
H
1.9
60000
|
L
H
1.9
84460
|
L
H
1.9
84460
|
L
H
1.9
84460
|
| iTonic Holdings Ordinary |
|
9.4
|
0.6
|
L
 -9.8%
H
0.6
0.6
|
L
 25%
H
0.4
1.1
|
L
 10%
H
0.4
1.1
|
L
 -12.7%
H
0.4
1.1
|
L
 -84.9%
H
0.4
32
|
L
H
0.4
32
|
L
H
0.4
32
|
L
H
0.4
32
|
| Ceribell Inc |
|
841.7
|
22.7
|
L
 2.4%
H
22.2
22.8
|
L
 -1.1%
H
21.4
23.4
|
L
 7.0%
H
20.4
24.3
|
L
 69.6%
H
10.9
24.3
|
L
 -1.1%
H
10.0
26.0
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
| Anteris Tech Global Corp |
|
270.7
|
6.6
|
L
 8.4%
H
6.0
6.8
|
L
 45.7%
H
4.4
6.8
|
L
 33%
H
4.4
6.8
|
L
 3.5%
H
3.3
6.8
|
L
 11.7%
H
2.3
8.8
|
L
H
2.3
8.8
|
L
H
2.3
8.8
|
L
H
2.3
8.8
|
| Beta Bionics Inc |
|
726.4
|
16.5
|
L
 0.2%
H
16.2
17.6
|
L
 -2.9%
H
16.2
19.0
|
L
 -43.6%
H
16.0
32.6
|
L
 -21.4%
H
16.0
32.7
|
L
H
8.9
32.7
|
L
H
8.9
32.7
|
L
H
8.9
32.7
|
L
H
8.9
32.7
|
| Kestra Medical Tech Ltd |
|
1,441.8
|
24.7
|
L
 4.7%
H
23.6
25.0
|
L
 10.7%
H
22.1
25.0
|
L
 -9.6%
H
21.4
28.8
|
L
 -6.4%
H
21.4
30
|
L
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
| Sanuwave Health Inc |
|
234.6
|
27.4
|
L
 -0.4%
H
27.2
28.6
|
L
 -2.6%
H
26.6
28.6
|
L
 -15.2%
H
26.6
32.9
|
L
 -9.7%
H
25.8
36.2
|
L
 -15.4%
H
24.8
46.6
|
L
 -15.4%
H
24.8
46.6
|
L
 -15.4%
H
24.8
46.6
|
L
 -15.4%
H
24.8
46.6
|
| SS Innovations Intl Inc |
|
1,068.8
|
5.5
|
L
 1.3%
H
5.4
5.9
|
L
 -0.2%
H
5.3
6.0
|
L
 -3.5%
H
5.1
6.2
|
L
 -44.3%
H
5.0
10.0
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
| Medline Inc Ordinary Shares |
|
38,248.1
|
46.0
|
L
 6.1%
H
43.4
46.1
|
L
 5.9%
H
42.2
46.1
|
L
 10.4%
H
38.5
46.1
|
L
 12.1%
H
38
46.1
|
L
 12.1%
H
38
46.1
|
L
 12.1%
H
38
46.1
|
L
 12.1%
H
38
46.1
|
L
 12.1%
H
38
46.1
|